Education
About Us
Working with TipRanks
Follow Us
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
Earnings Data
Report Date
Mar 31, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.18Last Year’s EPS
-0.18Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook for DiaMedica Therapeutics. While there were positive developments in the preeclampsia program and a strong cash position, challenges such as slow enrollment in the stroke trial and increased operating expenses indicate areas of concern.Company Guidance
Positive Interim Results for DM199 in Preeclampsia
The interim results from Part 1a of the Phase 2 trial in South Africa showed statistically significant reductions in both systolic and diastolic blood pressure, improved uterine artery blood flow, and no placental barrier crossing, indicating a strong safety profile.
Increased Cash Position
As of September 30, 2025, DiaMedica's cash, cash equivalents, and short-term investments stood at $55.3 million, an increase from $30 million as of June 30, 2025, due to net proceeds from a July private placement.
No Safety Concerns in ReMEDy2 Stroke Trial
The independent Data Safety Monitoring Board reported no safety concerns after reviewing safety data from the first 50 participants in the ReMEDy2 stroke trial.
DMAC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DMAC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $6.31 | $5.42 | -14.10% |
Aug 12, 2025 | $5.22 | $6.00 | +14.94% |
May 13, 2025 | $3.98 | $4.00 | +0.50% |
Mar 17, 2025 | $5.99 | $5.21 | -13.02% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Diamedica Therapeutics Inc (DMAC) report earnings?
Diamedica Therapeutics Inc (DMAC) is schdueled to report earning on Mar 31, 2026, TBA (Confirmed).
What is Diamedica Therapeutics Inc (DMAC) earnings time?
Diamedica Therapeutics Inc (DMAC) earnings time is at Mar 31, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DMAC EPS forecast?
DMAC EPS forecast for the fiscal quarter 2025 (Q4) is -0.18.